tirzepatide synergy nash In the SYNERGY-NASH trial, researchers assessed the efficacy and safety of once Eli Lilly's tirzepatide shows promise

Heres how it works: Step 1: Clinical assessment - Your new or current provider will review your treatment history

Additional specificity analysis was conducted to compare the outcomes of GLP-1 RA users with those of patients receiving other second-line antihyperglycemic treatments, including thiazolidinediones (TZDs), DPP-4is, or sulfonylureas (SUs)

Long-Term Weight Management Designed for ongoing use, supporting gradual, sustainable weight loss rather than short-term results

Available at: 5 Frank, RG, Garfield RL

What if I don't feel anything after my first injection

As demand for long-term weight management solutions continues to rise, home delivery of GLP-1 injectables is expected to gain further traction across Australia